Exposure to antazoline-naphazoline eye drops during pregnancy and the risk of congenital malformations: a Danish nationwide cohort study.
Vilde Marie ThomsethVanja CejvanovicEspen Jimenez-SolemHenrik E PoulsenTor Paaske UtheimJon T AndersenPublished in: Acta ophthalmologica (2018)
Exposure to antazoline-naphazoline eye drops in the first trimester of pregnancy appears not to be associated with increased teratogenic risk.